Global Molecular Diagnostics Market Report: 2014 Edition


#212971

59pages

Koncept Analytics

$ 800

In Stock

Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of ‘silent champion’ of the healthcare industry since this segment influences more than half of the decision-making in the overall healthcare industry.
 
Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity and thus, have been receiving greater inclination from physicians and affiliates.
 
The molecular diagnostics procedures for infectious diseases including CT/NG, HPV; encompasses four major disciplines: Virology, Bacteriology, Genetics and Blood Screening. Due to certain underlying factors, the oncology segment of the market is poised to undergo noteworthy expansion in the near future and thereby driving the molecular diagnostics market on the holistic basis. As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of oncology and reimbursement trend.
 
The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides detailed information pertaining to its superset market, i.e. the diagnostics and the IVD industry. It further discusses the various trends, growth drivers and challenges faced by the industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry players including Roche Holdings, Novartis, Hologic and Qiagen are profiled herein.
 
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have projected the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output.
Table of Content

1. Diagnostics: An Overview
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics
 
2. Diagnostics Market
2.1 Global In Vitro Diagnostics (IVD) Market
  • Market Value
  • Market Segmentation
  • Regional Breakdown
2.2 Global Molecular Diagnostics Market
  • Market Value
  • Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
  • Global Market Value
  • Global Market Volume
  • US Market Value
2.2.2 CT/NG
  • Global Market Value
  • Global Market Volume
  • US Market Value
2.2.3 Global Genetic Testing Market
  • Global Market Value
3. Market Dynamics
3.1 Industry Trends and Developments
3.1.1 Moderately Complex Tests on the Rise
3.1.2 Decentralization and Pricing Pressures to Continue
3.1.3 Industry Consolidation on the Rise
3.1.4 Growing Point-of-Care Diagnostics
3.2 Growth Drivers
3.2.1 Increasing CT/NG Prevalence in the US
3.2.2 Ageing Population on the Rise
3.2.3 Rising Healthcare Expenditure
3.2.4 Improving Economic Conditions
3.2.5 US Guidelines Promoting Regular Screening
3.2.6 Rising Incidence of Diabetes
3.2.7 Opportunities for Oncology Diagnostics
3.3 Challenges
3.3.1 Reimbursement Guidelines Still Unclear
3.3.2 Regulatory Hurdles

4. Competitive Landscape
  • Molecular Diagnostics Market Share
  • CT/NG Market Share
  • HPV Market Share
5. Company Profiles
5.1 Roche Holding AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
  • Promoting Innovation and Research
  • Strengthening Biotech Capabilities
5.2 Novartis AG
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
  • Expansion through R&D and Aggressive Pipeline 
  • Leaner Business Model with Focus on Innovation
5.3 Hologic Inc.
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
  • Seeking Expansion through Acquisitions
  • Enhancing Research and Development
5.4 Qiagen NV
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
  • Extending Products and Tests Portfolio
  • Seeking Expansion through Acquisitions
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
Major M&A in Diagnostics
Cancer Care Cost by Cancer Site (2010 and 2020E)
Top 20 IVD Companies by Revenue (2012)
Growth of Molecular Companies (2002-2012)
Dependent & Independent Variables (2007-2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
IVD Market – Segments by Technology
Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market Segment/Product Line
Global IVD Market (2006-2013E)
Global IVD Market Share by Segment (2013)
IVD Market Share by Geographical Region (2013E)
Global Molecular Diagnostics Market (2005-2013E)
Molecular Diagnostics Market Share by Segment (2013)
Molecular Diagnostics Market Share by Discipline (2013E)
Global HPV Market by Value (2010-2014E)
Global HPV Market by Volume (2010-2014E)
Global Pap Test Market (2013E)
Estimated Penetration of Liquid Based Cytology Tests (2012)
Global CT/NG Market by Value (2011-2015E)
Global CT/NG Market by Volume (2011-2015E)
Global Genetic Testing Market (2007-2013E)
Molecular Laboratories by Testing Menu
Global Average Selling Price (2010-2014E)
Incidence of Chlamydia and Gonorrhoea in the US (2000-2012)
Global Ageing Population (2007-2013)
Ageing Population in China (2008-2014)
Comparison of Aging Population (2012)
Global Healthcare Spending (2005-2015E)
Global GDP (2001-2013)
World GDP per Capita (2005-2013)
World Diabetic Population (2006-2013)
Oncology Market, the US (2014-2020E)
Global IVD Market Share by Company (2013E)
Global Molecular Diagnostics Market Share by Company (2013)
Global CT/NG Market Share by Company (2013)
Movements in Global CT/NG Market Share (2011-2014E)
Global HPV Market Share by Company (2013)
Movements in Global HPV Market Share (2010-2014E)
Roche’s Revenues by Business Segments (2013)
Diagnostics’ Revenues by Sub-Segments, Roche (2013) 
Revenues and Net Income, Roche (2010-2013) 
R&D Investments, Roche (2010-2013) 
Novartis’ Revenue Share by Business Segments (2013)
Novartis’ Vaccines and Diagnostics’ Revenues by Geographies (2013)
Net Sales and Net Income, Novartis (2010-2013)
Revenue Share by Business Segments, Hologic (2013)
Revenue Share by Geographies, Hologic (2013)
Revenue and Net Income, Hologic (2010-2013)
Revenue Share by Customer Classes Served, Qiagen (2013)
Revenue Share by Geographies, Qiagen (2013)
Net Sales and Net Income, Qiagen (2010-2013)
Global Molecular Diagnostics Market Forecast (2007-2017F)